Effects of lung volume reduction surgery for emphysema on glycolipidic hormones

Chest

Volumn 134, Issue 1, 2008, Pages 30-37

  Mineo, Davide ^a   Ambrogi, Vincenzo ^a   Frasca, Luca ^a   Cufari, Maria Elena ^a   Pompeo, Eugenia ^a   Mineo, Tommaso Claudio ^a,b  

^a TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

COPD; Ghrelin; Insulin; Leptin; Lung volume reduction surgery; Resistin

Indexed keywords

ADIPONECTIN; CHOLESTEROL; FATTY ACID; GHRELIN; GLYCOLIPIDIC HORMONE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HORMONE; INSULIN; LEPTIN; RESISTIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY COMPOSITION; BODY FAT; BODY MASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; ENDOSCOPIC SURGERY; FEMALE; FORCED EXPIRATORY VOLUME; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; INTERMETHOD COMPARISON; LUNG EMPHYSEMA; LUNG RESECTION; MALE; METABOLIC PARAMETERS; NUTRITIONAL STATUS; PRIORITY JOURNAL; PULMONARY REHABILITATION; RESIDUAL VOLUME; RESPIRATORY FUNCTION; THORACOSCOPY; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT REFUSAL; VIDEO ASSISTED THORACOSCOPIC SURGERY;

EID: 47549114730     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.07-3042     Document Type: Article

References (38)

1. Wouters EFM, Kreutzberg EC, Schols AMWJ. Systemic effects in COPD. Chest 2002; 121(suppl):127S-130S
2. Orozko-Levi M. Structure and function of the respiratory muscles in patients with COPD: impairment or adaptation? Eur Respir J Suppl 2003; 46:41S-51S
3. Creutzberg EC, Casaburi R. Endocrinological disturbances in chronic obstructive pulmonary disease. Eur Respir J Suppl 2003; 46:76S-80S
4. Schols AMWJ. Nutritional and metabolic modulation in chronic obstructive pulmonary disease management. Eur Respir J Suppl 2003; 46:81S-86S
5. Congleton J. The pulmonary cachexia syndrome: aspects of energy balance. Proc Nutr Soc 1999; 58:321-328
6. Engelen MP, Schols AMWJ, Lamers RJ, et al. Different patterns of chronic tissue wasting among patients with chronic obstructive pulmonary disease. Clin Nutr 1999; 18: 275-278
7. Vestbo J, Prescott E, Almdal T, et al. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. Am J Respir Crit Care Med 2006; 173:79-83
8. Yang Yi-Meng, Tie-Ying S, Xin-Min L. The role of serum leptin and tumoral necrosis factor-alpha in malnutrition of male chronic obstructive pulmonary disease patients. Chin Med J (Engl) 2006; 119:628-633
9. Zaloga GP. Gh-relin, diet and pulmonary function. Chest 2005; 128:1084-1086
10. Cooper JD, Patterson GA. Lung volume reduction surgery for severe emphysema. Chest Surg Clin N Am 1995; 5:815-831
11. Gelb AF, McKenna RJ Jr, Brenner M, et al. Lung function 5 yr after lung volume reduction surgery for emphysema. Am J Respir Crit Care Med 2001; 163:1562-1566
12. Pompeo E, Marino M, Nofroni I, et al. Reduction pneumoplasty versus respiratory rehabilitation: a randomized trial. Ann Thorac Surg 2000; 70:948-954
13. Mineo TC, Pompeo E, Mineo D, et al. Resting energy-expenditure and metabolic changes after lung volume reduction surgery for emphysema. Ann Thorac Surg 2006; 87: 1003-1008
14. American Thoracic Society. Surveillance for respiratory hazards in the occupational setting. Am Rev Respir Dis 1982; 126:952-956
15. Jones PW, Quirk FH, Baveystock CM, et al. A self-complete measure of health status for chronic airflow limitation: the St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992; 145:1321-1327
16. Steiner MC, Barton RL, Singh SJ, et al. Bedside methods versus dual energy X-ray absorptiometry for body composition measurement in COPD. Eur Respir J 2002; 19:626-631
17. Bonora E, Kiechl S, Willeit J, et al. Prevalence of insulin-resistance in metabolic disorders: the Bruneck Study. Diabetes 1998; 47:1643-1649
18. Lacasse Y, Wong E, Guyatt GH, et al. Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. Lancet 1996; 348:1115-1119
19. Powers AC. Diabetes mellitus. In: Braunwald E, Fauci AS, Kasper DL, et al, eds. Harrison's principles of internal medicine. 15th ed. New York, NY: McGraw-Hill, 2001; 2109-2137
20. Cancello R, Tounian A, Poitou Ch, et al. Adiposity signals, genetic and body weight regulation in humans. Diabetes Metab 2004; 30:215-227
21. Meier U, Gressner MA. Endocrine regulation of energy matabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clin Chem 2004; 50:1511-1525
22. Lazarczyk MA, Lazarczyk M, Grzela T. Ghrelin: a recently discovered gut-brain peptide. Int J Mol Med 2003; 12:279-287
23. Sauerwein HP, Schols AMW. Glucose metabolism in chronic lung disease. Clin Nutr 2002; 21:367-371
24. Jakobsson P, Jorfeldt L, von Schenck H. Fat metabolism and its response to infusion of insulin and glucose in patients with advanced chronic obstructive pulmonary disease. Clin Physiol 1995; 15:319-329
25. Balausubramanian VP, Varkey B. Chronic obstructive pulmonary disease: effects beyond the lungs. Curr Opin Pulm Med 2006; 12:106-112
26. Karakas S, Karadag F, Karul AB, et al. Circulating leptin and body composition in chronic obstructive pulmonary disease. Int J Clin Pract 2005; 59:1167-1170
27. Çalikoglu M, Şahin G, Unlu A, et al. Leptin and TNF-α levels in patients with chronic obstructive pulmonary disease and their relationship to nutritional parameters. Respiration 2004; 71:45-50
28. Creutzburg EC, Wouters EFM, Vanderhoven-Augustin IML, et al. Disturbances in leptin metabolism are related to energy imbalance during acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 162: 1239-1245
29. Wang QY, Zhang H, Yan X, et al. Serum resistin and leptin in patients with chronic obstructive pulmonary disease and their relationship to nutritional state. Zhonghua Jie He He Hu Xi Za Zhi 2005; 28:445-447
30. Itoh T, Nagaya N, Yoshikawa M, et al. Elevated plasma ghrelin level in underweight patients with cronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004; 170: 879-882
31. Luo F, Liu X, Li S, et al. Circulating ghrelin in patients with chronic obstructive pulmonary disease. Nutrition 2004; 21: 793-798
32. Nagaya N, Kojima M, Kangawa K. Ghrelin, a novel growth hormone-releasing peptide, in the treatment of cardiopulmonary-associated cachexia. Intern Med 2006; 45:127-134
33. Christensen PJ, Paine R III, Curtis JL, et al. Weight gain after lung volume reduction surgery is not correlated with improvement in pulmonary mechanics. Chest 1999; 116:1601-1607
34. Nezu K, Yoshikawa M, Yoneda T, et al. The change in body composition after bilateral lung volume reduction surgery for underweight patients with severe emphysema. Lung 2000; 178:381-389
35. Takayama T, Shindoh C, Kurokawa Y, et al. Effects of lung volume reduction surgery for emphysema on oxygen cost of breathing. Chest 2003; 123:1847-1852
36. Mineo TC, Ambrogi V, Pompeo E, et al. Body weight and nutritional changes after reduction pneumoplasty in severe emphysema: a randomized study. J Thorac Cardiovasc Surg 2002; 124:660-667
37. Mineo TC, Ambrogi V, Mineo D, et al. Bone mineral density improvement after lung-volume-reduction surgery for severe emphysema. Chest 2005; 127:1960-1966
38. Becker MD, Berkmen YM, Austin JH, et al. Lung volumes and after lung volume reduction surgery. Am J Respir Crit Care Med 1998; 157:1593-1599